Global Insulin Market by Manufacturers, Regions, Type and Application, Forecast to 2021

According to Custom Market Inights analysis, The global insulin market is expected to register a healthy CAGR during the period from 2016 to 2025. This report studies the insulin status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the insulin by product type and applications/end industries.

Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.

Scope of the Report:

This report focuses on the Insulin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Novartis

Novo Nordisk

Boehringer Ingelheim

Bristol-Myers Squibb

Eli Lilly

MannKind

Sanofi

Merck

Bioton

GEA

Emisphere

Salix Pharmaceuticals

Gan & Lee

Dongbao

United Laboratories (TUL)

Takeda Pharmaceutical Company

Shihuida PHARMA Group

Henan Tian Fang Pharmaceutical

Disha Pharmaceutical Group

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America, Middle East and Africa

Market Segment by Type, covers

Ultra-short-acting insulin

Short-acting insulin

In effect insulin

Long-acting insulin

Market Segment by Applications, can be divided into

Type 1 diabetes

Type 2 diabetes

Others diabetes

There are 13 Chapters to deeply display the global Insulin market.

Chapter 1, to describe Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin, with sales, revenue, and price of Insulin, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Insulin market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Insulin sales channel, distributors, traders, dealers, appendix and data source.

Table of Contents

Global Insulin Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Market Overview

1.1 Insulin Introduction

1.2 Market Analysis by Type

1.2.1 Ultra-short-acting insulin

1.2.2 Short-acting insulin

1.2.3 In effect insulin

1.3 Market Analysis by Applications

1.3.1 Type 1 diabetes

1.3.2 Type 2 diabetes

1.3.3 Others diabetes

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA

1.4.1.2 Canada

1.4.1.3 Mexico

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany

1.4.2.2 France

1.4.2.3 UK

1.4.2.4 Russia

1.4.2.5 Italy

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China

1.4.3.2 Japan

1.4.3.3 Korea

1.4.3.4 India

1.4.3.5 Southeast Asia

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil

1.4.4.2 Egypt

1.4.4.3 Saudi Arabia

1.4.4.4 South Africa

1.4.4.5 Nigeria

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Insulin Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Novartis Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.2 Novo Nordisk

2.2.1 Business Overview

2.2.2 Insulin Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.3 Boehringer Ingelheim

2.3.1 Business Overview

2.3.2 Insulin Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Boehringer Ingelheim Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.4 Bristol-Myers Squibb

2.4.1 Business Overview

2.4.2 Insulin Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Bristol-Myers Squibb Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.5 Eli Lilly

2.5.1 Business Overview

2.5.2 Insulin Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.6 MannKind

2.6.1 Business Overview

2.6.2 Insulin Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 MannKind Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.7 Sanofi

2.7.1 Business Overview

2.7.2 Insulin Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Sanofi Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.8 Merck

2.8.1 Business Overview

2.8.2 Insulin Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Merck Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.9 Bioton

2.9.1 Business Overview

2.9.2 Insulin Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Bioton Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.10 GEA

2.10.1 Business Overview

2.10.2 Insulin Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 GEA Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.11 Emisphere

2.11.1 Business Overview

2.11.2 Insulin Type and Applications

2.11.2.1 Type 1

2.11.2.2 Type 2

2.11.3 Emisphere Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.12 Salix Pharmaceuticals

2.12.1 Business Overview

2.12.2 Insulin Type and Applications

2.12.2.1 Type 1

2.12.2.2 Type 2

2.12.3 Salix Pharmaceuticals Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.13 Gan & Lee

2.13.1 Business Overview

2.13.2 Insulin Type and Applications

2.13.2.1 Type 1

2.13.2.2 Type 2

2.13.3 Gan & Lee Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.14 Dongbao

2.14.1 Business Overview

2.14.2 Insulin Type and Applications

2.14.2.1 Type 1

2.14.2.2 Type 2

2.14.3 Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.15 United Laboratories (TUL)

2.15.1 Business Overview

2.15.2 Insulin Type and Applications

2.15.2.1 Type 1

2.15.2.2 Type 2

2.15.3 United Laboratories (TUL) Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.16 Takeda Pharmaceutical Company

2.16.1 Business Overview

2.16.2 Insulin Type and Applications

2.16.2.1 Type 1

2.16.2.2 Type 2

2.16.3 Takeda Pharmaceutical Company Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.17 Shihuida PHARMA Group

2.17.1 Business Overview

2.17.2 Insulin Type and Applications

2.17.2.1 Type 1

2.17.2.2 Type 2

2.17.3 Shihuida PHARMA Group Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.18 Henan Tian Fang Pharmaceutical

2.18.1 Business Overview

2.18.2 Insulin Type and Applications

2.18.2.1 Type 1

2.18.2.2 Type 2

2.18.3 Henan Tian Fang Pharmaceutical Insulin Sales, Price, Revenue, Gross Margin and Market Share

2.19 Disha Pharmaceutical Group

2.19.1 Business Overview

2.19.2 Insulin Type and Applications

2.19.2.1 Type 1

2.19.2.2 Type 2

2.19.3 Disha Pharmaceutical Group Insulin Sales, Price, Revenue, Gross Margin and Market Share

3 Global Insulin Market Competition, by Manufacturer

3.1 Global Insulin Sales and Market Share by Manufacturer

3.2 Global Insulin Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Insulin Manufacturer Market Share

3.3.2 Top 6 Insulin Manufacturer Market Share

3.4 Market Competition Trend

4 Global Insulin Market Analysis by Regions

4.1 Global Insulin Sales, Revenue and Market Share by Regions

4.1.1 Global Insulin Sales by Regions (2011-2016)

4.1.2 Global Insulin Revenue by Regions (2011-2016)

4.2 North America Insulin Sales and Growth (2011-2016)

4.3 Europe Insulin Sales and Growth (2011-2016)

4.4 Asia-Pacific Insulin Sales and Growth (2011-2016)

4.5 South America Insulin Sales and Growth (2011-2016)

4.6 Middle East and Africa Insulin Sales and Growth (2011-2016)

5 North America Insulin by Countries

5.1 North America Insulin Sales, Revenue and Market Share by Countries

5.1.1 North America Insulin Sales by Countries (2011-2016)

5.1.2 North America Insulin Revenue by Countries (2011-2016)

5.2 USA Insulin Sales and Growth (2011-2016)

5.3 Canada Insulin Sales and Growth (2011-2016)

5.4 Mexico Insulin Sales and Growth (2011-2016)

6 Europe Insulin by Countries

6.1 Europe Insulin Sales, Revenue and Market Share by Countries

6.1.1 Europe Insulin Sales by Countries (2011-2016)

6.1.2 Europe Insulin Revenue by Countries (2011-2016)

6.2 Germany Insulin Sales and Growth (2011-2016)

6.3 UK Insulin Sales and Growth (2011-2016)

6.4 France Insulin Sales and Growth (2011-2016)

6.5 Russia Insulin Sales and Growth (2011-2016)

6.6 Italy Insulin Sales and Growth (2011-2016)

7 Asia-Pacific Insulin by Countries

7.1 Asia-Pacific Insulin Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Insulin Sales by Countries (2011-2016)

7.1.2 Asia-Pacific Insulin Revenue by Countries (2011-2016)

7.2 China Insulin Sales and Growth (2011-2016)

7.3 Japan Insulin Sales and Growth (2011-2016)

7.4 Korea Insulin Sales and Growth (2011-2016)

7.5 India Insulin Sales and Growth (2011-2016)

7.6 Southeast Asia Insulin Sales and Growth (2011-2016)

8 South America, Middle East and Africa Insulin by Countries

8.1 South America, Middle East and Africa Insulin Sales, Revenue and Market Share by Countries

8.1.1 South America, Middle East and Africa Insulin Sales by Countries (2011-2016)

8.1.2 South America, Middle East and Africa Insulin Revenue by Countries (2011-2016)

8.2 Brazil Insulin Sales and Growth (2011-2016)

8.3 Saudi Arabia Insulin Sales and Growth (2011-2016)

8.4 Egypt Insulin Sales and Growth (2011-2016)

8.5 Nigeria Insulin Sales and Growth (2011-2016)

8.6 South Africa Insulin Sales and Growth (2011-2016)

9 Insulin Market Segment by Type

9.1 Global Insulin Sales, Revenue and Market Share by Type (2011-2016)

9.1.1 Global Insulin Sales and Market Share by Type (2011-2016)

9.1.2 Global Insulin Revenue and Market Share by Type (2011-2016)

9.2 Ultra-short-acting insulin Sales Growth and Price

9.2.1 Global Ultra-short-acting insulin Sales Growth (2011-2016)

9.2.2 Global Ultra-short-acting insulin Price (2011-2016)

9.3 Short-acting insulin Sales Growth and Price

9.3.1 Global Short-acting insulin Sales Growth (2011-2016)

9.3.2 Global Short-acting insulin Price (2011-2016)

9.4 In effect insulin Sales Growth and Price

9.4.1 Global In effect insulin Sales Growth (2011-2016)

9.4.2 Global In effect insulin Price (2011-2016)

10 Insulin Market Segment by Application

10.1 Global Insulin Sales Market Share by Application (2011-2016)

10.2 Type 1 diabetes Sales Growth (2011-2016)

10.3 Type 2 diabetes Sales Growth (2011-2016)

10.4 Others diabetes Sales Growth (2011-2016)

10.5 Sales Growth (2011-2016)

11 Insulin Market Forecast (2016-2021)

11.1 Global Insulin Sales, Revenue and Growth Rate (2016-2021)

11.2 Insulin Market Forecast by Regions (2016-2021)

11.3 Insulin Market Forecast by Type (2016-2021)

11.4 Insulin Market Forecast by Application (2016-2021)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Future Trend

12.2 Distributors, Traders and Dealers

13 Appendix

13.1 Methodology

13.2 Analyst Introduction

13.3 Data Source

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Jacob Thomass